Drug intelligence / Profile preview

N20 blocking peptide

Development stage
Preclinical
Modality
Peptides
Administration
In Vitro, Ex Vivo, Potentially Intratumoral (experimental Research Use Only)
01

Overview

The **N20 blocking peptide** is a synthetic peptide that specifically blocks the binding between **CRIPTO** (also known as TDGF1) and **GRP78** (Glucose-Regulated Protein 78, also known as HSPA5), thereby inhibiting CRIPTO/GRP78-dependent signaling. This pathway is implicated in promoting aggressive tumor phenotypes and chemoresistance in hepatocellular carcinoma and potentially other cancers. By blocking CRIPTO/GRP78 interaction, the N20 peptide reduces downstream AKT signaling and enhances tumor responsiveness to agents such as sorafenib. The peptide is used in research settings to evaluate CRIPTO signaling dependency and therapeutic modulation in cancer models[2].

Other names
GRP78 N20 blocking peptideGRP-78 N20 blocking peptideGRP 78 N20 blocking peptidesc1050Psc-1050Psc 1050P
02

Targets

HSPA5 (Heat shock protein family A member 5)

Beyond the preview

Go deeper on N20 blocking peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N20 blocking peptide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call